My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Anales de Medicina Interna
Print version ISSN 0212-7199
Abstract
KHOSRAVI SHAHI, P.; CASTILLO RUEDA, A. del and DIAZ MUNOZ DE LA ESPADA, V. M.. Waldenström's Macroglobulinemia. An. Med. Interna (Madrid) [online]. 2006, vol.23, n.6, pp.291-293. ISSN 0212-7199.
Waldenströms macroglobulinemia is an uncommon B-cell lymphoproliferative disorder characterized by bone marrow infiltration of luymphoplasmatic lymphoma, although sometimes there is a extramedullary lymphoma (nodal), with demonstration of an IgM monoclonal gammopathy. It must be distinguished from monoclonal gammopathy of undetermined significance and IgM- related disorders. The median survival of patients with Waldenströms macroglobulinemia averages 5 years. Asymptomatic cases should not be treated. Symtomatic cases could be treated with alkylating agents, nucleoside analogues (fludarabine or cladribine), and the monoclonal antibody rituximab. For the managment of hyperviscosity and neuropathies plasmapheresis could be used successfully.
Keywords : Macroglobulinemia; Waldenström; Lymphoplasmatic lymphoma; IgM; Hyperviscosity.